CME - Insider Move: Charles P Carey Invests $240K In CME Gr Stock | Benzinga
A significant insider buy by Charles P Carey, Director at CME Gr (NASDAQ:CME), was executed on June 27, and reported in the recent SEC filing.
What Happened: Carey demonstrated confidence in CME Gr by purchasing 1,237 shares, as reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday. The total value of the transaction is $240,101.
In the Thursday's morning session, CME Gr's shares are currently trading at $195.63, experiencing a up of 0.22%.
Discovering CME Gr: A Closer Look
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018, it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.